Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.

@article{Zhou2015CombinationalTW,
  title={Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.},
  author={Jianyu Zhou and L V Lv and Changwei Lin and Gui Xian Hu and Yihang Guo and Meirong Wu and Buning Tian and Xiaorong Li},
  journal={Molecular medicine reports},
  year={2015},
  volume={12 4},
  pages={5407-14}
}
Colorectal cancer (CRC) is the third most common cancer with a very poor prognosis predominantly due to its high rate of tumor invasion and migration, and its resistance to anti‑epidermal growth factor receptor (EGFR) therapy. Although CRC has been widely studied, the underlying molecular mechanism remains to be elucidated. MicroRNA (miR)‑133b has been… CONTINUE READING